Skip to main content
. 2021 Jan 15;23(3):281–287. doi: 10.4103/aja.aja_81_20

Table 1.

Body and organ weight in mice of experimental groups (n = 6) after 50 days of treatment (mean±standard deviation)

Group ND D DGSH15 DGSH30
Initial body weight (g) 26.91±2.97 28.52±2.04 26.25±1.76 29.13±1.11
Final body weight (g) 28.02±1.53 26.33±1.64 23.03±2.17 24.91±1.46
Weight gain (%) 3.9±1.6 −4.3±6.5 −6.5±4.6 −16.3±4.6
Left testis (g) 0.09±0.01 0.08±0.04 0.08±0.01 0.09±0.02
Relative left testicular weight (%) 0.3±0.0 0.3±0.1 0.4±0.0 0.4±0.1
Right testis (g) 0.09±0.01 0.08±0.04 0.08±0.01 0.09±0.01
Relative right testicular weight (%) 0.3±0.0 0.3±0.1 0.4±0.0 0.4±0.0
Seminal vesicle (g) 0.28±0.04 0.24±0.16 0.13±0.12 0.21±0.04
Relative seminal vesicle weight (%) 1.0±0.2 0.9±0.5 0.6±0.2* 0.8±0.2*
Left epididymis (g) 0.04±0.01 0.04±0.02 0.04±0.01 0.05±0.02
Relative left epididymis weight (%) 0.1±0.0 0.2±0.0 0.2±0.0 0.2±0.1*
Right epididymis (g) 0.04±0.01 0.04±0.02 0.04±0.01 0.05±0.01
Relative right epididymis weight (%) 0.1±0.0 0.2±0.1 0.2±0.0 0.2±0.0*

*P < 0.05, the indicated group compared with ND Group. ND: nondiabetic control group; D: diabetic control group; DGSH15: diabetic mice treated with GSH at 15 mg kg−1 BW; DGSH30: diabetic mice treated with GSH at 30 mg kg−1 BW; GSH: glutathione; BW: body weight